Biopharmaceutical Outsourcing Market 2028 By Service | The Insight Partners

    Biopharmaceutical Outsourcing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Service (Clinical Trials, Drug Discovery, API Development, Contract Production and Packaging, Non-Clinical Services, Others)

    Report Code: TIPRE00018822 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

    MARKET INTRODUCTION

    The biopharmaceutical industry is one of the significant contributors to global economic progress. Due to globalization, outsourcing of the biopharmaceutical processes has progressed to a great extent. Outsourcing also helped corporate in cost reduction and better focus on core business segments. The complexity of operations and technology-oriented industry companies started finding it feasible to outsource functions to experts. Outsourcing is the cost-saving alternative of biopharmaceutical business in the strategic decision.

    MARKET DYNAMICS

    Competitive market and advent of generics is an opportunity for small pharma companies to drive the augmentation of the biopharmaceutical outsourcing market. However, rising cost of drug discovery, regulatory policies and drug recalls are worry factors that may hinders the enlargement of the biopharmaceutical outsourcing market.

    MARKET SCOPE

    The "Biopharmaceutical Outsourcing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of biopharmaceutical outsourcing market with detailed market segmentation by service. The biopharmaceutical outsourcing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in biopharmaceutical outsourcing market and offers key trends and opportunities in the market.

    MARKET SEGMENTATION

    The biopharmaceutical outsourcing market is segmented on the basis of service. Based on service, the market is segmented as clinical trials, drug discovery, api development, contract production and packaging, non-clinical services, and others.

    REGIONAL FRAMEWORK

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the biopharmaceutical outsourcing market based onvarious segments.It also provides market size and forecast estimates from year 2020 to2028with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biopharmaceutical outsourcing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

    The report analyzes factors affecting biopharmaceutical outsourcing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biopharmaceutical outsourcing market in these regions.



    Get more information on this report :

    MARKET PLAYERS


    The report covers key developments in the biopharmaceutical outsourcing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biopharmaceutical outsourcing market are anticipated to have lucrative growth opportunities in the future with the rising demand for biopharmaceutical outsourcing in the global market. Below mentioned is the list of few companies engaged in the biopharmaceutical outsourcing market.

    The report also includes the profiles of key players in biopharmaceutical outsourcing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
    - SARTORIUS AG
    - EMCURE PHARMACEUTICALS LTD
    - BIOPHARMA SERVICES INC.
    - LAMBDA THERAPEUTIC RESEARCH LTD.
    - BAXTER HEALTHCARE CORPORATION
    - KEYRUS BIOPHARMA
    - QUINTILES INC.
    - APTUIT LLC
    - KBI BIOPHARM
    - ICON PLC
    The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


    Get more information on this report :

    TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Biopharmaceutical Outsourcing Market - By Service
    1.3.2 Biopharmaceutical Outsourcing Market - By Region
    1.3.2.1 By Country
    2. KEY TAKEAWAYS
    3. RESEARCH METHODOLOGY
    4. BIOPHARMACEUTICAL OUTSOURCING MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS
    5. BIOPHARMACEUTICAL OUTSOURCING MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
    6. BIOPHARMACEUTICAL OUTSOURCING MARKET - GLOBAL MARKET ANALYSIS
    6.1. BIOPHARMACEUTICAL OUTSOURCING - GLOBAL MARKET OVERVIEW
    6.2. BIOPHARMACEUTICAL OUTSOURCING - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE
    7. BIOPHARMACEUTICAL OUTSOURCING MARKET - REVENUE AND FORECASTS TO 2028 - SERVICE
    7.1. OVERVIEW
    7.2. SERVICE MARKET FORECASTS AND ANALYSIS
    7.3. CLINICAL TRIALS
    7.3.1. Overview
    7.3.2. Clinical Trials Market Forecast and Analysis
    7.4. DRUG DISCOVERY
    7.4.1. Overview
    7.4.2. Drug Discovery Market Forecast and Analysis
    7.5. API DEVELOPMENT
    7.5.1. Overview
    7.5.2. API Development Market Forecast and Analysis
    7.6. CONTRACT PRODUCTION AND PACKAGING
    7.6.1. Overview
    7.6.2. Contract Production and Packaging Market Forecast and Analysis
    7.7. NON-CLINICAL SERVICES
    7.7.1. Overview
    7.7.2. Non-Clinical Services Market Forecast and Analysis
    7.8. OTHERS
    7.8.1. Overview
    7.8.2. Others Market Forecast and Analysis
    8. BIOPHARMACEUTICAL OUTSOURCING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    8.1. NORTH AMERICA
    8.1.1 North America Biopharmaceutical Outsourcing Market Overview
    8.1.2 North America Biopharmaceutical Outsourcing Market Forecasts and Analysis
    8.1.3 North America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
    8.1.4 North America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
    8.1.4.1 United States Biopharmaceutical Outsourcing Market
    8.1.4.1.1 United States Biopharmaceutical Outsourcing Market by Service
    8.1.4.2 Canada Biopharmaceutical Outsourcing Market
    8.1.4.2.1 Canada Biopharmaceutical Outsourcing Market by Service
    8.1.4.3 Mexico Biopharmaceutical Outsourcing Market
    8.1.4.3.1 Mexico Biopharmaceutical Outsourcing Market by Service
    8.2. EUROPE
    8.2.1 Europe Biopharmaceutical Outsourcing Market Overview
    8.2.2 Europe Biopharmaceutical Outsourcing Market Forecasts and Analysis
    8.2.3 Europe Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
    8.2.4 Europe Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
    8.2.4.1 Germany Biopharmaceutical Outsourcing Market
    8.2.4.1.1 Germany Biopharmaceutical Outsourcing Market by Service
    8.2.4.2 France Biopharmaceutical Outsourcing Market
    8.2.4.2.1 France Biopharmaceutical Outsourcing Market by Service
    8.2.4.3 Italy Biopharmaceutical Outsourcing Market
    8.2.4.3.1 Italy Biopharmaceutical Outsourcing Market by Service
    8.2.4.4 Spain Biopharmaceutical Outsourcing Market
    8.2.4.4.1 Spain Biopharmaceutical Outsourcing Market by Service
    8.2.4.5 United Kingdom Biopharmaceutical Outsourcing Market
    8.2.4.5.1 United Kingdom Biopharmaceutical Outsourcing Market by Service
    8.2.4.6 Rest of Europe Biopharmaceutical Outsourcing Market
    8.2.4.6.1 Rest of Europe Biopharmaceutical Outsourcing Market by Service
    8.3. ASIA-PACIFIC
    8.3.1 Asia-Pacific Biopharmaceutical Outsourcing Market Overview
    8.3.2 Asia-Pacific Biopharmaceutical Outsourcing Market Forecasts and Analysis
    8.3.3 Asia-Pacific Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
    8.3.4 Asia-Pacific Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
    8.3.4.1 Australia Biopharmaceutical Outsourcing Market
    8.3.4.1.1 Australia Biopharmaceutical Outsourcing Market by Service
    8.3.4.2 China Biopharmaceutical Outsourcing Market
    8.3.4.2.1 China Biopharmaceutical Outsourcing Market by Service
    8.3.4.3 India Biopharmaceutical Outsourcing Market
    8.3.4.3.1 India Biopharmaceutical Outsourcing Market by Service
    8.3.4.4 Japan Biopharmaceutical Outsourcing Market
    8.3.4.4.1 Japan Biopharmaceutical Outsourcing Market by Service
    8.3.4.5 South Korea Biopharmaceutical Outsourcing Market
    8.3.4.5.1 South Korea Biopharmaceutical Outsourcing Market by Service
    8.3.4.6 Rest of Asia-Pacific Biopharmaceutical Outsourcing Market
    8.3.4.6.1 Rest of Asia-Pacific Biopharmaceutical Outsourcing Market by Service
    8.4. MIDDLE EAST AND AFRICA
    8.4.1 Middle East and Africa Biopharmaceutical Outsourcing Market Overview
    8.4.2 Middle East and Africa Biopharmaceutical Outsourcing Market Forecasts and Analysis
    8.4.3 Middle East and Africa Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
    8.4.4 Middle East and Africa Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
    8.4.4.1 South Africa Biopharmaceutical Outsourcing Market
    8.4.4.1.1 South Africa Biopharmaceutical Outsourcing Market by Service
    8.4.4.2 Saudi Arabia Biopharmaceutical Outsourcing Market
    8.4.4.2.1 Saudi Arabia Biopharmaceutical Outsourcing Market by Service
    8.4.4.3 U.A.E Biopharmaceutical Outsourcing Market
    8.4.4.3.1 U.A.E Biopharmaceutical Outsourcing Market by Service
    8.4.4.4 Rest of Middle East and Africa Biopharmaceutical Outsourcing Market
    8.4.4.4.1 Rest of Middle East and Africa Biopharmaceutical Outsourcing Market by Service
    8.5. SOUTH AND CENTRAL AMERICA
    8.5.1 South and Central America Biopharmaceutical Outsourcing Market Overview
    8.5.2 South and Central America Biopharmaceutical Outsourcing Market Forecasts and Analysis
    8.5.3 South and Central America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
    8.5.4 South and Central America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
    8.5.4.1 Brazil Biopharmaceutical Outsourcing Market
    8.5.4.1.1 Brazil Biopharmaceutical Outsourcing Market by Service
    8.5.4.2 Argentina Biopharmaceutical Outsourcing Market
    8.5.4.2.1 Argentina Biopharmaceutical Outsourcing Market by Service
    8.5.4.3 Rest of South and Central America Biopharmaceutical Outsourcing Market
    8.5.4.3.1 Rest of South and Central America Biopharmaceutical Outsourcing Market by Service
    9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BIOPHARMACEUTICAL OUTSOURCING MARKET
    9.1 North America
    9.2 Europe
    9.3 Asia-Pacific
    9.4 Middle East and Africa
    9.5 South and Central America
    10. INDUSTRY LANDSCAPE
    10.1. MERGERS AND ACQUISITIONS
    10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    10.3. NEW PRODUCT LAUNCHES
    10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    11. BIOPHARMACEUTICAL OUTSOURCING MARKET, KEY COMPANY PROFILES
    11.1. SARTORIUS AG
    11.1.1. Key Facts
    11.1.2. Business Description
    11.1.3. Products and Services
    11.1.4. Financial Overview
    11.1.5. SWOT Analysis
    11.1.6. Key Developments
    11.2. EMCURE PHARMACEUTICALS LTD
    11.2.1. Key Facts
    11.2.2. Business Description
    11.2.3. Products and Services
    11.2.4. Financial Overview
    11.2.5. SWOT Analysis
    11.2.6. Key Developments
    11.3. BIOPHARMA SERVICES INC.
    11.3.1. Key Facts
    11.3.2. Business Description
    11.3.3. Products and Services
    11.3.4. Financial Overview
    11.3.5. SWOT Analysis
    11.3.6. Key Developments
    11.4. LAMBDA THERAPEUTIC RESEARCH LTD.
    11.4.1. Key Facts
    11.4.2. Business Description
    11.4.3. Products and Services
    11.4.4. Financial Overview
    11.4.5. SWOT Analysis
    11.4.6. Key Developments
    11.5. BAXTER HEALTHCARE CORPORATION
    11.5.1. Key Facts
    11.5.2. Business Description
    11.5.3. Products and Services
    11.5.4. Financial Overview
    11.5.5. SWOT Analysis
    11.5.6. Key Developments
    11.6. KEYRUS BIOPHARMA
    11.6.1. Key Facts
    11.6.2. Business Description
    11.6.3. Products and Services
    11.6.4. Financial Overview
    11.6.5. SWOT Analysis
    11.6.6. Key Developments
    11.7. QUINTILES INC.
    11.7.1. Key Facts
    11.7.2. Business Description
    11.7.3. Products and Services
    11.7.4. Financial Overview
    11.7.5. SWOT Analysis
    11.7.6. Key Developments
    11.8. APTUIT LLC
    11.8.1. Key Facts
    11.8.2. Business Description
    11.8.3. Products and Services
    11.8.4. Financial Overview
    11.8.5. SWOT Analysis
    11.8.6. Key Developments
    11.9. KBI BIOPHARM
    11.9.1. Key Facts
    11.9.2. Business Description
    11.9.3. Products and Services
    11.9.4. Financial Overview
    11.9.5. SWOT Analysis
    11.9.6. Key Developments
    11.10. ICON PLC
    11.10.1. Key Facts
    11.10.2. Business Description
    11.10.3. Products and Services
    11.10.4. Financial Overview
    11.10.5. SWOT Analysis
    11.10.6. Key Developments
    12. APPENDIX
    12.1. ABOUT THE INSIGHT PARTNERS
    12.2. GLOSSARY OF TERMS
    The List of Companies

    1. SARTORIUS AG
    2. EMCURE PHARMACEUTICALS LTD
    3. BIOPHARMA SERVICES INC.
    4. LAMBDA THERAPEUTIC RESEARCH LTD.
    5. BAXTER HEALTHCARE CORPORATION
    6. KEYRUS BIOPHARMA
    7. QUINTILES INC.
    8. APTUIT LLC
    9. KBI BIOPHARM
    10. ICON PLC
    TIPRE00018822
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount